Dr. Kavita Singh, MD

Dr. Singh practices at Anaheim Endoscopy Center in Anaheim, California.

Dr. Singh's NPI, 1255597985, was assigned on August 1, 2008. Dr. Singh graduated from Saint Louis University School Of Medicine in 2004. Dr. Singh holds California license C192898.

Dr. Singh's primary practice is Anaheim Endoscopy Center, at 1211 West La Palma, Suite 301, Anaheim, CA 92801. The practice phone is (714) 284-0737.

Dr. Singh's primary practice is Anaheim Endoscopy Center in Anaheim, California. Dr. Singh is also affiliated with AHMC Anaheim Regional Medical Center. The medical group on file is Associated Gastroenterology Medical Group. Dmand AI also links Dr. Singh to 4 more hospitals, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Singh practices, 7 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Singh's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Singh is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Singh's licenses on file in 2 states: California and Illinois.

Dmand AI lists acid reflux, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, gastroenteritis, gastrointestinal bleeding, hemorrhoids and intestinal or bowel obstruction among the conditions Dr. Singh treats.

CMS data shows 334 Medicare services from Dr. Singh across 7 procedure codes in 2024, for 198 Medicare patients. Medicare paid $36,181 for them.

CMS counts 198 Medicare patients who saw Dr. Singh in 2024. The largest group is 65 to 74, with 78 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 76% are also on Medicaid. Their average risk score is 3.12, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Singh's median patient age at 61, with 54% women.

In 2024, Dr. Singh wrote 292 Medicare Part D claims for 160 patients. 84% of them were for generic drugs. CMS names the drug for 193 of them, across 5 drugs with 11 or more claims each, at $17,032 in total drug cost. In 2023, CMS named 308 claims across 10 drugs.

Dr. Singh accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Singh as offering telehealth. CMS counts 60 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Singh, more than 66% of the clinicians it reports for that procedure.

Dmand AI links 8 papers to Dr. Singh, published from 2005 to 2021. The most frequent topics are Models, Molecular, Protein Structure, Tertiary and Antigens, Protozoan. Dr. Singh has published most often in J Biol Chem.

CMS Open Payments shows 656 general payments to Dr. Singh from 47 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Abbvie Inc. paid the most, $3,046.

Dmand AI lists 1 award for Dr. Singh, most recently CMS Stage 1 2012 in 2012.

Dr. Singh graduated from Saint Louis University School Of Medicine in 2004.

Dr. Singh is in network with 16 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.